167 related articles for article (PubMed ID: 18597628)
1. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.
Anderson PH; Sawyer RK; Moore AJ; May BK; O'Loughlin PD; Morris HA
J Bone Miner Res; 2008 Nov; 23(11):1789-97. PubMed ID: 18597628
[TBL] [Abstract][Full Text] [Related]
2. Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume.
Lee AM; Sawyer RK; Moore AJ; Morris HA; O'Loughlin PD; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():159-62. PubMed ID: 24309068
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model.
Anderson PH; Sawyer RK; May BK; O'Loughlin PD; Morris HA
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):592-5. PubMed ID: 17267207
[TBL] [Abstract][Full Text] [Related]
4. The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels.
Anderson PH; Lee AM; Anderson SM; Sawyer RK; O'Loughlin PD; Morris HA
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):288-92. PubMed ID: 20236618
[TBL] [Abstract][Full Text] [Related]
5. Long-term vitamin D deficiency in older adult C57BL/6 mice does not affect bone structure, remodeling and mineralization.
van der Meijden K; Buskermolen J; van Essen HW; Schuurman T; Steegenga WT; Brouwer-Brolsma EM; Langenbach GEJ; van Ruijven LJ; den Heijer M; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Nov; 164():344-352. PubMed ID: 26361014
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
8. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
[TBL] [Abstract][Full Text] [Related]
9. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
10. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
[TBL] [Abstract][Full Text] [Related]
11. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
[TBL] [Abstract][Full Text] [Related]
12. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
13. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D activities and metabolic bone disease.
Ryan JW; Anderson PH; Turner AG; Morris HA
Clin Chim Acta; 2013 Oct; 425():148-52. PubMed ID: 23911750
[TBL] [Abstract][Full Text] [Related]
15. Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents.
Lee AM; Anderson PH; Sawyer RK; Moore AJ; Forwood MR; Steck R; Morris HA; O'Loughlin PD
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):284-7. PubMed ID: 20398759
[TBL] [Abstract][Full Text] [Related]
16. Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance.
Shieh A; Chun RF; Ma C; Witzel S; Meyer B; Rafison B; Swinkels L; Huijs T; Pepkowitz S; Holmquist B; Hewison M; Adams JS
J Clin Endocrinol Metab; 2016 Aug; 101(8):3070-8. PubMed ID: 27192696
[TBL] [Abstract][Full Text] [Related]
17. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
Ng AH; Frick KK; Krieger NS; Asplin JR; Cohen-McFarlane M; Culbertson CD; Kyker-Snowman K; Grynpas MD; Bushinsky DA
Calcif Tissue Int; 2014 May; 94(5):531-43. PubMed ID: 24481706
[TBL] [Abstract][Full Text] [Related]
18. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.
Kogawa M; Anderson PH; Findlay DM; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):277-80. PubMed ID: 20304055
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell bone disease: response to vitamin D and calcium.
Adewoye AH; Chen TC; Ma Q; McMahon L; Mathieu J; Malabanan A; Steinberg MH; Holick MF
Am J Hematol; 2008 Apr; 83(4):271-4. PubMed ID: 17924548
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]